Stocks and InvestingStocks and Investing
Fri, September 1, 2023
Thu, August 31, 2023
Wed, August 30, 2023
Tue, August 29, 2023

Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $319 on, Aug 29th, 2023


Published on 2024-10-28 06:10:35 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $321 to $319 on, Aug 29th, 2023.

Matthew has made no other calls on BGNE in the last 4 months.



There are 4 other peers that have a rating on BGNE. Out of the 4 peers that are also analyzing BGNE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Rebecca Liang of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $196 on, Friday, June 30th, 2023


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $287 on, Thursday, August 17th, 2023
  • Xiling Chen of "JP Morgan" Maintained at Buy with Increased Target to $300 on, Monday, August 7th, 2023
  • Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $275 on, Monday, July 17th, 2023